alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
about
Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutininsGuillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.Pathophysiological implication of ganglioside GM3 in early mouse embryonic development through apoptosis.Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells.Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells.Ganglioside GM3 and its biological functions.Cerebral sponginess and GM3 gangliosidosis; ultrastructure and probable pathogenesis.Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some propertiesMonoclonal antibody specific to alpha-2-->3-linked deaminated neuraminyl beta-galactosyl sequence.Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides.Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (NeuAc)3LacCer) and to its 9-O-acetylated derivative.Monoclonal antibody MACG1 distinguishes between different molecular species of the ganglioside GM3.Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.Production of monoclonal antibodies specific for ganglioside GD3.Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).Degradation of human intestinal glycosphingolipids by extracellular glycosidases from mucin-degrading bacteria of the human fecal flora.Release of pig leukocytes during pig kidney perfusion and characterization of pig lymphocyte carbohydrate xenoantigens.Mechanism for the negative regulation of cell proliferation by ganglioside GM3 in high glucose-treated glomerular mesangial cells.Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells.Lipid microarrays identify key mediators of autoimmune brain inflammation.Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathyTwo chicken monoclonal antibodies specific for heterophil Hanganutziu-Deicher antigensAn acidic glycosphingolipid, monosialo-ganglioside GM3, is a potent physiological inducer for monocytic differentiation of human promyelocytic leukemia cell line HL-60 cellsGanglioside GM3 inhibits the proliferation of cultured keratinocytesThe total synthesis of ganglioside GM3Incorporation and localisation of ganglioside GM3 in human intimal atherosclerotic lesionsDifferential distribution of ganglioside GM3 in seminiferous tubule and epididymis of adult rats
P921
Q28368055-2A012A1F-1233-4E5F-95B0-EC77F4DE4BBAQ31874413-01918411-50A2-4FD0-897D-8A764687939DQ33224795-8A14C4C9-8171-47A4-8737-4694549EED05Q33768401-115BB252-B4EE-45FF-82D3-AB1C9633575EQ34350804-D9C69E5D-6612-4044-9393-EE051D2DF86CQ34368328-925C98AF-1E83-4100-80EA-D279E03A29FBQ37443090-ACE0EBB4-0F37-436D-BC7F-14B4B788CC0BQ39938224-CEB89097-46EC-4969-9DC9-E5A182BC6369Q40297814-129CCAB3-1DE6-4FD2-B9EE-CF6F69EE0161Q41322595-56DDED57-FD32-460E-8F69-4142B5779E6BQ41574992-5A3DF764-11A0-48FF-8556-C345EA4D228EQ41643428-C1894BF6-B7EB-4097-A166-381DE66D4DB9Q41843927-52B27963-DFCF-458F-8939-8F32D5D26ED3Q42197538-D2BD12D3-A446-4383-8605-98432F465828Q42806281-FA06636E-077E-4F49-93D1-FC5F5AD49FF6Q43604576-AE827D77-8868-4832-8822-26B4109D2D8BQ43850028-3815B20F-B88E-486C-BBBA-9DAD2677ADAAQ44114317-ABF9750E-0943-400E-8DB4-A78D63F6E893Q44206858-CEC9DB67-F071-4459-AB25-42A9FCC43AEDQ44570341-FAA85EBE-40CF-41D6-9B97-71F0EBBB2700Q44854607-FBE4BABC-FFE4-4748-ACB5-2B90C30919E5Q46531013-DA4FF1D8-70D9-4E93-956B-C9F6A4927978Q46845275-74E00C53-2B5A-4F27-A313-025047ECF468Q58854453-7E63156D-987E-4D55-B76E-489DF315128FQ67541123-D32CFF6D-D1BD-47A6-8E39-9E38CDF2209DQ69848133-7784B080-8348-4595-952E-8AF5FBA260E5Q70723956-701EC239-E885-49A4-8DC1-EAE09792C8A1Q73229636-135CF82D-C6B7-44D6-B9EE-D1C63F9FCE28Q73893099-DE5D47B2-7371-4A8F-B54D-6F3063D052D4Q74457885-4C0C1657-B71D-4B3A-8D20-820C23447C17
P921
alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
@en
type
label
alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
@en
altLabel
(Gal)1 (Glc)1 (Neu5Ac)1 (Cer)1
@en
(N-Acetylneuraminyl)-D-galactosyl-D-glucosylceramide
@en
GM3
@en
NeuAcα2-3Galβ1-4Glcβ-Cer
@en
α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
@en
prefLabel
alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
@en
P31
P2153
P683
P2017
[H][C@]1(O[C@@](C[C@H](O)[C@H] ...... H]1O)C(O)=O)[C@H](O)[C@H](O)CO
P2063
LMSP0601AJ00